However, in a study that included RA patients with severe disease undergoing anti-TNF-α-infliximab therapy visfatin levels were not associated with inflammation or MS and infliximab infusion did not yield significant changes in visfatin levels [82]. The gene discussed is NAMPT; the disease is rheumatoid arthritis.